4.7 Article

Fucoidan Protects against Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Preventing Mitochondrial Function Injury

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy

Weili Li et al.

Summary: Doxorubicin is an effective chemotherapeutic agent, but its clinical use is limited due to the severe risk of cardiotoxicity. This study finds that harpagoside has significant cardioprotective effects in DICT mouse and rat cardiomyocytes by targeting the interaction between p53 and Parkin to restore mitophagy.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Biochemistry & Molecular Biology

Protective effects of fucoidan against kidney diseases: Pharmacological insights and future perspectives

Md Sarwar Zahan et al.

Summary: Fucoidan, a sulfated polysaccharide extracted from brown seaweed, has pharmacological benefits in the management of chronic kidney disease. It has been found to reduce inflammation, oxidative stress, and fibrosis in the kidney by targeting multiple signaling systems associated with CKD. Low molecular weight fucoidan shows promise in therapeutic development despite the limitations of larger molecular size.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Pharmacology & Pharmacy

Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice

Araceli Lerida-Viso et al.

Summary: Many anticancer drugs can cause premature aging in healthy tissues, resulting in accelerated aging processes and adverse effects in patients. Cardiotoxicity is a major limiting factor in the use of doxorubicin as a cancer treatment, leading to long-term morbidity and mortality. In this study, it was demonstrated that induction of senescence in the heart contributes to impaired cardiac function in mice treated with doxorubicin. Elimination of senescent cells using the senolytic Navitoclax significantly reduced senescence and cardiotoxicity markers, and restored cardiac function in mice. These results suggest the potential clinical use of senolytic therapies to alleviate cardiotoxicities induced by chemotherapy.

PHARMACOLOGICAL RESEARCH (2022)

Article Surgery

Effect of Mitochondrial Antioxidant (Mito-TEMPO) on Burn-Induced Cardiac Dysfunction

Jake J. Wen et al.

Summary: The study demonstrated that the mitochondrial-specific antioxidant Mito-TEMPO partially improved burn-induced cardiac dysfunction by protecting cardiac mitochondrial function through multiple signaling pathways.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)

Article Biochemistry & Molecular Biology

The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice

Ming-Yang Tsai et al.

Summary: This study demonstrates the hepatoprotective effect of fucoidan against liver injury by suppressing inflammatory responses and acting as an antioxidant. Molecular data supported the use of fucoidan for liver disorders.

MOLECULES (2021)

Article Pharmacology & Pharmacy

The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin

Xiaoyu Fu et al.

Summary: Doxorubicin (DOX) is a cancer chemotherapeutic agent with cardiotoxicity issues, while PAESe has shown effectiveness in mitigating DOX-induced cardiac hypertrophy through its antioxidative properties. The study found that DOX affects mitochondrial function and iron-sulfur cluster biogenesis, whereas PAESe protects against these effects and enhances cellular respiration.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes

Xiaoxue Yu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Inhibition of the proteasome preserves Mitofusin-2 and mitochondrial integrity, protecting cardiomyocytes during ischemia-reperfusion injury

Ivonne Olmedo et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Article Biochemistry & Molecular Biology

Gastric protective activities of fucoidan from brown alga Kjellmaniella crassifolia through the NF-κB signaling pathway

Yue Hu et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Article Chemistry, Applied

Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo

Catarina Oliveira et al.

CARBOHYDRATE POLYMERS (2019)

Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Article Biochemistry & Molecular Biology

The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer

Meilan Xue et al.

FOOD & FUNCTION (2018)

Review Medicine, Research & Experimental

Mitochondrial dysfunction in pathophysiology of heart failure

Bo Zhou et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Biochemistry & Molecular Biology

In vitro and in vivo evaluation of anti-arthritic, antioxidant efficacy of fucoidan from Undaria pinnatifida (Harvey) Suringar

Abdul-Rehman Phull et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)

Article Cell Biology

Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase

Yanti Octavia et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)

Review Toxicology

Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone

Roberto Marques Damiani et al.

ARCHIVES OF TOXICOLOGY (2016)

Review Oncology

Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management

Giuseppe Curigliano et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Review Biochemistry & Molecular Biology

The concomitant management of cancer therapy and cardiac therapy

Emanuela Salvatorelli et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)

Article Pharmacology & Pharmacy

Fucosterol, a sterol extracted from Sargassum fusiforme, shows antidepressant and anticonvulsant effects

Xing-Hua Zhen et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2015)

Article Integrative & Complementary Medicine

Total Flavonoids from Clinopodium chinense (Benth.) O. Ktze Protect against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo

Rong Chang Chen et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)

Review Pharmacology & Pharmacy

Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms

Luc Rochette et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2015)

Review Cardiac & Cardiovascular Systems

Cardiac Mitochondria and Reactive Oxygen Species Generation

Yeong-Renn Chen et al.

CIRCULATION RESEARCH (2014)

Review Cardiac & Cardiovascular Systems

Cardiomyocyte autophagy and cancer chemotherapy

Dan L. Li et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)

Review Endocrinology & Metabolism

Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin

Jenelle Govender et al.

JOURNAL OF PINEAL RESEARCH (2014)

Article Food Science & Technology

Safety Evaluation of Excessive Ingestion of Mozuku Fucoidan in Human

Sunao Abe et al.

JOURNAL OF FOOD SCIENCE (2013)

Article Pharmacology & Pharmacy

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

Oktay Tacar et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)

Article Biochemistry & Molecular Biology

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

Sui Zhang et al.

NATURE MEDICINE (2012)

Review Chemistry, Medicinal

Therapies from Fucoidan; Multifunctional Marine Polymers

Janet Helen Fitton

MARINE DRUGS (2011)

Review Cardiac & Cardiovascular Systems

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

Michael S. Ewer et al.

NATURE REVIEWS CARDIOLOGY (2010)

Review Biochemistry & Molecular Biology

Doxorubicin: The Good, the Bad and the Ugly Effect

Cristina Carvalho et al.

CURRENT MEDICINAL CHEMISTRY (2009)

Review Cardiac & Cardiovascular Systems

Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management

Genzou Takemura et al.

PROGRESS IN CARDIOVASCULAR DISEASES (2007)

Review Cardiac & Cardiovascular Systems

Doxorubicin in experimental and clinical heart failure

Stefan Christiansen et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2006)

Article Medicine, General & Internal

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

SE Lipshultz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)